Grants Search Results
Need help? Call us at (888) 899-2253
Interested in applying for a St. Baldrick's Foundation grant? Learn more about the grant application process.
Showing 41-51 of 51 results
Olga Toro-Salazar M.D.
Funded: 07-01-2011
through 06-30-2013
Funding Type: Supportive Care Research Grant
Institution Location:
Hartford, CT
Institution: Connecticut Children's Medical Center
Research in the last 30 years has had a wonderful impact on the survival rate of kids with many types of cancers. However, aggressive treatment regimens on children's young bodies have many negative side effects. One class of chemotherapy drugs, anthracyclines, have been used to effectively treat more than 135,000 childhood cancer survivors, but cause significant risk for cardiovascular disease by the time these children reach their 30s. This research will use Cardiac Magnetic Resonance Imaging and chemical markers in the blood to identify heart damage caused by anthracyclines before symptoms begin, thereby reducing long-term life-threatening heart conditions for pediatric cancer survivors.
Kathleen Ruccione Ph.D., M.P.H., R.N.
Funded: 07-01-2011
through 06-30-2013
Funding Type: Supportive Care Research Grant
Institution Location:
Los Angeles, CA
Institution: Children's Hospital Los Angeles
Transfusions with packed red blood cells (PRBCs) are commonly used when children treated for cancer develop anemia (low red blood cell count). PRBC transfusions carry iron that can be deposited in various body tissues, such as the heart. The body cannot remove this iron overload by itself, and if it stays in the heart, it can cause damage (cardiomyopathy). At this time, we do not know how often patients have extra iron in their heart after PRBC transfusions. This study uses a magnetic resonance image (MRI) test that can measure iron and learn about other things that might affect the heart, such as anthracycline chemotherapy and what effect iron-related cardiomyopathy has on daily life. The overall goal is to increase the length and quality of survival for people successfully treated for cancer during childhood.
Lauri Linder Ph.D.
Funded: 07-01-2011
through 10-31-2013
Funding Type: Supportive Care Research Grant
Institution Location:
Salt Lake City, UT
Institution: University of Utah
affiliated with Huntsman Cancer Institute
Adolescents with cancer experience many symptoms resulting from their disease and its treatment. Recognizing and managing these contributes to improved quality of life during treatment and on into survivorship. This study uses an approach that allows adolescents to identify clusters describing their symptom experience from their perspective. The purpose is to develop and test the use of a computer-based tool exploring symptom clusters among adolescents with cancer. The goal of these findings is to provide data to support use of the tool in a larger group of adolescents and to enhance communication between them and healthcare providers.
Kristina Hardy Ph.D., Clinical Psychology
Funded: 09-01-2010
through 12-31-2013
Funding Type: Supportive Care Research Grant
Institution Location:
Washington, DC
Institution: Children's National Medical Center and Children’s National Research Institute (CNRI)
affiliated with George Washington University
Children with brain tumors and acute lymphoblastic leukemia are at risk for developing learning and memory problems as a result of their disease and treatments. Since we currently cannot prevent this, difficulties are addressed after they appear, with only modest improvements. A computerized cognitive training program, easily used at home with little oversight from parents or professionals, has been tested in survivors of pediatric cancer with memory problems; this project tests it on children during treatment, before the problems develop. If effective, the program has considerable potential to improve the quality of life in pediatric cancer patients.
Jonathan Espenschied M.D.
Funded: 07-01-2010
through 12-31-2012
Funding Type: Supportive Care Research Grant
Institution Location:
Duarte, CA
Institution: Beckman Research Institute of the City of Hope
Cancer affects every part of patients and their families' lives. Self-image, thinking clearly, anxiety, depression, social isolation and fear of recurrence are all problems that teens and young adults with cancer face, while resuming normal development and being monitored for many problems caused by cancer and its treatment. This research is to create developmentally sensitive information and make it available through touch-screen technology, connecting teens and young adults with their health care team and community resources in real-time. This helps identify, communicate and maximize the benefits of clinical care while helping them reintegrate into school and work.
Jennifer Mack M.D., M.P.H.
Funded: 07-01-2010
through 06-30-2011
Funding Type: Supportive Care Research Grant
Institution Location:
Boston, MA
Institution: Dana-Farber Cancer Institute
affiliated with Boston Children's Hospital, Harvard Medical School
Little is known about the long-term impact of communication about prognosis on children with cancer and their families. The goal of this project is to increase parents' ability to make value-driven decisions for care of their children with cancer and to adjust to this life-changing event in the best way possible. A longitudinal observational study evaluates long-term outcomes, using questionnaire-based parent interviews to assess parental decision- making and psychological and medical outcomes of disclosure. The cohort involves 194 children diagnosed between April 2003 and May 2005, so long-term assessment of their outcomes is now possible. Dr. Mack is funded by P.A.L.S. Bermuda with funds raised through the St. Baldrick's Foundation.
Mary Hooke Ph.D.
Funded: 07-01-2010
through 10-31-2013
Funding Type: Supportive Care Research Grant
Institution Location:
Minneapolis, MN
Institution: Children's Hospitals and Clinics of Minnesota
affiliated with Children's - St. Paul
Fatigue is a pervasive, distressing symptom for children and teens with cancer. Decreasing fatigue and improving physical activity are important to provide energy for the normal activities of childhood that are important to ongoing development. A small, cost-effective device called the FitBit measures motion and provides daily feedback to the wearer. Children ages 6 to 18 in maintenance treatment for acute lymphoblastic leukemia use the FitBit, and researchers determine if it is accurate, if it helps childhood cancer patients to be more active, and if more active patients have less fatigue when getting steroids during treatment.
Peter Cole M.D.
Funded: 07-01-2010
through 06-30-2011
Funding Type: Supportive Care Research Grant
Institution Location:
Bronx, NY
Institution: Albert Einstein College of Medicine of Yeshiva University
affiliated with Montefiore Medical Center, Children's Hospital at Montefiore
Generously sponsored by Markit. Treatment for acute lymphoblastic leukemia can be particularly devastating to a child's developing brain, leading to deficient short-term memory and attention or more serious events like seizures or strokes. This research focuses on how the cough medicine dextromethorphan may help reverse severe, stroke-like neurotoxicity among children treated with chemotherapy drug methotrexate and could possibly also prevent such side effects before they occur. The most promising drugs will be rapidly advanced into clinical trials for children with leukemia, designed to decrease the neurotoxic effects of chemotherapy.
Olga Toro-Salazar M.D.
Funded: 01-01-1970
through 01-01-1970
Funding Type: Supportive Care Research Grant
Institution Location:
Nashville, TN
Institution: Vanderbilt University Medical Center
affiliated with Monroe Carell Jr. Children's Hospital at Vanderbilt
Many children survive cancer, but treatments that save lives can also damage the heart, placing survivors at risk for serious health problems later in life. Dr. Toro-Salazar and colleagues will utilize a pilot study to test EX@HOME. The 16-week, home-based exercise program is designed to help childhood cancer survivors safely improve fitness and protect heart health soon after completing therapy. EX@HOME uses a simple mobile app, a wearable fitness watch, and regular coaching support to make healthy physical activity accessible and sustainable for families. Results will provide critical early evidence to guide larger trials and support the development of scalable survivorship care programs, helping ensure that children not only survive cancer, but also go on to live long, healthy lives.
Brittany Ivory M.D., M.P.H.
Funded: 01-01-1970
through 01-01-1970
Funding Type: Supportive Care Research Grant
Institution Location:
Los Angeles, CA
Institution: Children's Hospital Los Angeles
Teens with leukemia go through tough treatments that make them feel tired and weak. This leads them to spend a lot of time sitting and lying down, which can worsen side effects and increase risk for chronic diseases like heart disease and diabetes. ReSeT1, is a program designed by Dr. Ivory to help teens receiving leukemia treatment reduce sitting time by taking short activity breaks using a Fitbit, health coaching, and an app-based chat group. Using an enhanced version called ReSeT2, which includes home activity equipment, additional coaching, peer support groups, and goal-based rewards, Dr. Ivory and colleagues will test 20 new teens comparing them to 20 who do not receive the program to see if it works. Small behavior changes will help cancer patients become more active during and after treatment to improve lifelong health.
Liora Schultz M.D.
Funded: 01-01-1970
through 01-01-1970
Funding Type: Supportive Care Research Grant
Institution Location:
New York, NY
Institution: Columbia University Medical Center
affiliated with Morgan Stanley Children’s Hospital, New York-Presbyterian
Dr. Schultz and team will examine what happens to children after CAR T therapy for leukemia, an immunotherapy that can put cancer into remission when standard treatments, such as chemotherapy, have failed. While many children now survive, doctors do not fully understand the long-term effects. Dr. Schultz's team will study 700 children who have received this therapy and will collect surveys from a subset of patients and caregivers about quality of life and real-world challenges. By combining medical data with patient experiences, this study will uniquely identify which children are most at risk for long term problems and why. This work will help doctors better predict these risks and guide follow-up care so children not only survive leukemia, but achieve prolonged years of highest quality and function after treatment.